Free preview

5α-Reductase Deficiency

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

5α-Reductase type 2 deficiency is an inherited condition in which the body makes too little dihydrotestosterone (DHT) from testosterone. In people with a 46,XY chromosome pattern, this can affect genital development before birth. External genitalia may be female-appearing, atypical, or male-appearing with a small penis or hypospadias. Testosterone can cause substantial physical changes at puberty. Fertility and treatment needs vary; care should reflect the person's anatomy, health and preferences.

Clinical Definition

5α-Reductase type 2 deficiency is an autosomal recessive SRD5A2-related 46,XY DSD caused by impaired conversion of testosterone to DHT. Reduced fetal DHT action affects external genital and prostate development; testosterone-dependent Wolffian structures are generally preserved, and Sertoli-cell AMH causes Müllerian regression. Pubertal testosterone can produce virilization despite persistent DHT deficiency. Phenotype ranges from isolated micropenis to female-appearing external genitalia.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses